This statistic depicts the cancer specialist input into MCO (managed care organization) coverage policy development in the United States, as of 2018. Some 20 percent of MCOs stated they have direct oncology specialist input in survivorship planning care.
Cancer specialist input into MCO coverage policy development in the United States as of 2018
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Oncology
Cancer facts
5
- Premium Statistic Global death rate - leading causes 2019
- Basic Statistic Cancer deaths worldwide by major type 2022
- Basic Statistic U.S. Americans with a history of cancer living 2004-2022
- Premium Statistic Number of new cancer cases in U.S. from 1999 to 2020
- Premium Statistic Deaths by cancer in the U.S. 1950-2019
Oncology market
6
- Premium Statistic Global oncology spending 2013-2024
- Basic Statistic Spending and growth worldwide in oncology market 2023-2027
- Premium Statistic Oncology medicine spending growth 2014-2018, by region
- Premium Statistic Predicted oncology spending in 2023, by region
- Premium Statistic Emerging cancer diagnostics market size by world region 2015 and 2023
- Basic Statistic Oncology therapeutic market growth U.S. 2016-2021, by segment
Companies
7
- Premium Statistic Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
- Premium Statistic Global top pharmaceutical companies by oncology market share 2017 and 2024
- Basic Statistic Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2023
- Basic Statistic Celgene's top product revenues 2013-2018
- Premium Statistic Bristol-Myers Squibb's top products based on revenue 2021-2023
- Basic Statistic U.S. venture investments in oncology companies 2006-2023
- Basic Statistic U.S. oncology company IPO money raised 2006-2023
Cancer drugs
5
- Premium Statistic Top 5 worldwide oncology products by revenue 2017 and 2024
- Premium Statistic Top 5 worldwide oncology products by market share 2017 and 2024
- Premium Statistic Availability of new cancer drugs by country as of 2018
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Premium Statistic Number of cancer drugs by cost and number of patients U.S. 2017
Research and development
6
- Premium Statistic FDA on breakthrough therapy requests by therapy area 2019
- Basic Statistic FDA on breakthrough therapy requests granted by therapy area 2019
- Premium Statistic Distribution of late phase oncology pipeline 2008 vs. 2018 by type
- Premium Statistic Number of cancer drugs in development in the U.S. 2005-2018
- Premium Statistic Time from R&D start to approval of select cancer drugs 2017
- Premium Statistic Total R&D costs including costs of capital for select cancer drugs 2017
Immuno-oncology
5
- Basic Statistic Worldwide top drug producing mechanisms of action by number of active compounds 2024
- Premium Statistic Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action
- Basic Statistic Global cancer immunotherapy market size 2023 and 2032 forecast
- Premium Statistic Global cancer immunotherapy sales share by type 2021 forecast
- Premium Statistic Leading cancer immunotherapy collaborations worldwide by value 2018
Treatment types
5
- Premium Statistic Distribution of treatment types for female breast cancer by stage 2018
- Basic Statistic Distribution of treatment types for prostate cancer 2010-2012
- Premium Statistic Distribution of treatment types for colon cancer by stage 2018
- Premium Statistic Distribution of treatment types for lung cancer in the U.S. 2018
- Basic Statistic Distribution of treatment types for non-Hodgkin lymphoma 2013
Physicians and patients
8
- Premium Statistic Number of oncologists per one million people by select country 2018
- Basic Statistic Number of active physicians in the U.S. 2024, by specialty area
- Basic Statistic Number of oncology specialty physicians in the U.S. 2016
- Premium Statistic Number of hours U.S. oncologists spend a week seeing patients 2018
- Premium Statistic Number of minutes U.S. oncologists spend with each patient 2018
- Basic Statistic Cancer patients using medication in select countries 2018
- Premium Statistic Cancer sufferers based on lifestyle habits by select country 2019
- Premium Statistic Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017
Further related statistics
9
- Total assets of UnitedHealth Group 2007-2023
- Net earnings of UnitedHealth Group 2007-2023
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Presence of mental ill health in England 2014, by gender
- Cancer mortality rate among men 2003-2007 by country
- MorphoSys' revenue 2006-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
Further Content: You might find this interesting as well
Statistics
- Total assets of UnitedHealth Group 2007-2023
- Net earnings of UnitedHealth Group 2007-2023
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Presence of mental ill health in England 2014, by gender
- Cancer mortality rate among men 2003-2007 by country
- MorphoSys' revenue 2006-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
Genentech. (May 7, 2019). Cancer specialist input into MCO coverage policy development in the United States as of 2018 [Graph]. In Statista. Retrieved June 11, 2024, from https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech. "Cancer specialist input into MCO coverage policy development in the United States as of 2018." Chart. May 7, 2019. Statista. Accessed June 11, 2024. https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech. (2019). Cancer specialist input into MCO coverage policy development in the United States as of 2018. Statista. Statista Inc.. Accessed: June 11, 2024. https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech. "Cancer Specialist Input into Mco Coverage Policy Development in The United States as of 2018." Statista, Statista Inc., 7 May 2019, https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/
Genentech, Cancer specialist input into MCO coverage policy development in the United States as of 2018 Statista, https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/ (last visited June 11, 2024)
Cancer specialist input into MCO coverage policy development in the United States as of 2018 [Graph], Genentech, May 7, 2019. [Online]. Available: https://www.statista.com/statistics/544270/cancer-specialist-input-in-mco-coverage-policy-in-us/